Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 3, 2025, the company approved 1,200 restricted stock units ( RSUs ), each...

Monday, January 13, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: PTC Therapeutics, Inc. has announced the approval of 1,200 restricted stock units (RSUs) as part of its inducement grants for two new employees. These awards, approved by the Compensation Committee on January 3, 2025, are in accordance with Nasdaq Listing Rule 5635(c)(4) and are aimed at enhancing employee compensation. The RSUs will vest over a four-year period, with 25% vesting each year, contingent upon the employees' continued service with the company.
Price reaction · baseline $43.94 (2025-01-10 close) · clean, no other PTCT news in the window
day 0 close
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Approval of 1,200 RSUs indicates growth and hiring at PTC Therapeutics.
  • Inducement grants are part of a strategy to attract talent.
  • RSUs vesting over four years reflect commitment to employee retention.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

WARREN, N.J. , Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that on Jan. 3, 2025 , the company approved 1,200 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to two new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.
The inducement grants were approved by PTC's Compensation Committee on Jan. 3, 2025, and are being made as an inducement material to each employee's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs each will vest over four years with 25% of the original number of shares vesting on each annual anniversary of the applicable employee's new hire date until fully vested, subject to the employee's continued service with the company through the applicable vesting dates.
For more information please contact:

Frequently Asked Questions

What are the restricted stock units approved by PTC?

PTC approved 1,200 restricted stock units representing the right to receive shares upon vesting.

When were the RSUs granted by PTC Therapeutics?

The RSUs were granted on January 3, 2025.

How will the RSUs vest for employees?

The RSUs will vest over four years, with 25% vesting each year on the anniversary date.

Why were the RSUs granted to new employees?

The RSUs were granted as an inducement for new hires to accept employment with PTC.

Who approved the RSU grants at PTC?

The PTC Compensation Committee approved the RSU grants.

ShareAdd on Google
Tags: PTCT Viatris Investor Conferences Healthcare restricted stock units Nasdaq employee compensation talent acquisition
Last updated: Jan 13, 2025

Biotech snapshot

Cash runway
$2229M liquidity · $0M/mo burn
Low dilution risk
Lead asset
AtalurenPhase 3
Cystic Fibrosis →

Catalyst track record

+74%
best trade around PTCT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for PTCT.

See every catalyst's timing & PoA →